本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enochian Biosciences Inc.

0.7000
0.0000
成交量:- -
成交额:6.42万
市值:4,251.66万
市盈率:-0.36
高:0.7000
开:0.7000
低:0.7000
收:0.7000
52周最高:2.99
52周最低:0.3928
股本:6,073.80万
流通股本:2,898.09万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.9447
每股收益(LYR):-2.1595
净资产收益率:-93.88%
总资产收益率:-9.94%
市净率:0.64
市盈率(LYR):-0.32

数据加载中...

2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/29

重要事件披露

Form 8-K - Current report
2023/07/12

重要事件披露

Form 8-K - Current report
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/27

重要事件披露

Form 8-K - Current report
2023/06/24

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]